Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
ENB-105 by Ennovabio for Inflammatory Bowel Disease: Likelihood of Approval
ENB-105 is under clinical development by Ennovabio and currently in Phase I for Inflammatory Bowel Disease. According to GlobalData, Phase...